Weight effects associated with antipsychotics: a comprehensive database analysis. - Wikidata - wikimedia - TriplyDB

Weight effects associated with antipsychotics: a comprehensive database analysis.

Weight effects associated with antipsychotics: a comprehensive database analysis.

http://www.wikidata.org/entity/Q44587936

about

Appetite stimulants for people with cystic fibrosis Aripiprazole partial agonism at 5-HT2C: a comparison of weight gain associated with aripiprazole adjunctive to antidepressants with high versus low serotonergic activities The Relationship between Body Weight Change and Body Constitutions of Traditional Chinese Medicine in Patients with Schizophrenia Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100 Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia New atypical antipsychotics for schizophrenia: iloperidone Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review.Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care.Health promotion intervention in mental health care: design and baseline findings of a cluster preference randomized controlled trial.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.Antipsychotic drugs and obesity.Almost all antipsychotics result in weight gain: a meta-analysis.Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication Implications of weight-based stigma and self-bias on quality of life among individuals with schizophrenia.Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.Pharmacogenetics of antipsychotic-induced side effects Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis.Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Reducing psychotropic pharmacotherapy in patients with severe mental illness: a cluster-randomized controlled intervention study.Metabolic Impairments Precede Changes in Hunger and Food Intake Following Short-Term Administration of Second-Generation Antipsychotics Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia Metabolic status and resistin in chronic schizophrenia over a 2-year period with continuous atypical antipsychotics.Review of the safety of second-generation antipsychotics: are they really "atypically" safe for youth and adults?Can bipolar disorder be viewed as a multi-system inflammatory disease?Evidence review and clinical guidance for the use of ziprasidone in Canada.Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia.Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial 2-Bromoterguride-a potential atypical antipsychotic drug without metabolic effects in rats.Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications Youth, caregiver, and prescriber experiences of antipsychotic-related weight gain.Sex-specific differences in side effects of psychotropic drugs: genes or gender?Strategies for successful clinical management of schizophrenia with ziprasidone.Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders.Statistically significant increase in weight caused by low-dose quetiapine.Schizophrenia: women bear a disproportionate toll of antipsychotic side effects.Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.

P2860

Q24194798-2C0475A5-B1D2-4DD7-8570-23EDCAA1D3D5 Q24615556-2CCD45C8-8DE0-49C7-B026-F6F81F58BEA0 Q30370448-BBCFD3C3-2C1F-4F4B-A8FE-1595802FF266 Q30410518-7836999B-3410-4F17-9446-D12DE66E7884 Q30459624-3FFF7FBB-6E99-4607-AEBD-2F7FCE3320B0 Q30482195-516945CA-D43B-4FF6-9B4A-905C07DF1483 Q33868229-87650261-0C1E-44A7-BDA8-F67821384BA8 Q34116503-04E53EF5-4120-46EF-ABC8-E0324025461D Q34302939-08747040-593D-4105-8DB8-9056BF29A5F1 Q34623350-45D4F8DB-F1D6-4811-AA45-8EF2BB62EC02 Q34641561-D9662EB1-F3FE-44AE-A97B-0F3B7C57555D Q34646095-F2400586-D161-486F-9674-F5BCEB4654F5 Q34648940-79FDE7D7-E1FC-4FB6-8CDC-9F977AD729D4 Q34661499-C00D6379-D329-47F2-9EEA-54B4E67A9E89 Q35064650-7E06E30B-EAA3-4F78-9C9B-9AF18440452B Q35101300-AA231F12-00F7-41BA-9E5C-56DC8D89BB4D Q35115972-47CE51A1-00CD-409C-AD96-32AF9FCD115C Q35237129-82E292AF-1343-4EA0-A8F9-2B4E45F365BA Q35566086-D8D9A8A1-2EF6-4063-8A37-3A25BCD345DD Q35577365-97C6DA16-2174-471B-843B-0CB926E4EFF8 Q35754726-F918968A-7463-46BB-B7A5-0D2798C652A9 Q35906535-2FACF199-7CF5-4FD9-9FB8-576D14692B56 Q36005869-1F740D89-00E8-47BA-9D89-AA2C18A0C492 Q36063735-19F3A210-9006-4500-8764-3DB8983FE84C Q36169130-56067FBC-4D50-4393-BA44-42AA7A6664DC Q36211690-539FF103-F521-4CBF-8AA1-7EF409529996 Q36302856-AB8ACB83-06EF-45CE-A7AE-F5CB8F467CAF Q36401142-3D08AC18-C636-4B2C-9823-B373E46881C8 Q36588607-BEE1D555-BC85-49F6-97B9-D781080B203F Q36981526-61D87BB2-8A4F-4956-8852-404E383EBA6E Q37042160-6C3BD20E-322B-4519-9566-EA9EC935DBCE Q37067125-129BE905-C54A-466A-8E93-C09C3D581134 Q37220366-1861659B-58B4-45C6-B557-2E7D4C63DDB8 Q37515292-7230A296-EFDC-4BA0-BAC8-B83856859957 Q37598900-DDAD2514-8BBB-49C0-923F-A883DF25663A Q37775630-343A1CE4-DEB5-41A1-8B41-62343922C78F Q37781124-77715B34-8046-49FF-8AD4-369AFBB49862 Q37793086-B89AD03B-C4E4-479C-B8F7-B1A187AD9B45 Q37887304-852E5D8B-8ABE-4124-B945-2C6CF194B4CF Q37926893-430A971E-3CF3-4C38-88B2-B6499D17AF37

P2860

Weight effects associated with antipsychotics: a comprehensive database analysis.

http://www.wikidata.org/entity/Q44587936

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Weight effects associated with antipsychotics: a comprehensive database analysis.

@en

Weight effects associated with antipsychotics: a comprehensive database analysis.

@nl

type

label

Weight effects associated with antipsychotics: a comprehensive database analysis.

@en

Weight effects associated with antipsychotics: a comprehensive database analysis.

@nl

prefLabel

Weight effects associated with antipsychotics: a comprehensive database analysis.

@en

Weight effects associated with antipsychotics: a comprehensive database analysis.

@nl

P1433

Q44587936-848531EE-FAF3-499B-8993-AA0235A1620C

P1476

Q44587936-C4371ABB-A0CE-4D56-AD3D-DC8E606C1F44

P2093

Q44587936-02A7DFE9-DBB4-4311-ACFA-6F351280B80A

Q44587936-5E707E16-4834-4543-AF2E-F21309DF84BC

Q44587936-709C1309-3120-4F91-B085-F19CE021FA37

Q44587936-7C9AAE91-0F2A-40BC-9656-F7067513906C

Q44587936-CE837944-E5A7-4919-8586-AD49395FB5EA

Q44587936-F4C0031F-82EB-4626-9575-2A2F594AD2ED

P304

Q44587936-A8CDFAD5-D88B-405E-99A0-5E8B715FE63D

P31

Q44587936-51584C16-E2C2-4671-B601-8F789604143C

P356

Q44587936-DF34F4EC-97FC-4143-BC5D-E7A90E85421D

P407

Q44587936-58334D26-18C9-4D06-B651-FA8E22440CBB

P433

Q44587936-4E75190D-B466-451C-B3EC-8E35C6B666B5

P478

Q44587936-F5559F6D-26A4-48C2-8828-D4D095555432

P50

Q44587936-C92116AB-5379-4740-A826-84D41EBC1226

P577

Q44587936-D49E3AB8-D1AC-44CE-BA9B-134826B5C889

P698

Q44587936-4342FAD7-6FFD-422C-99EA-CA80D5FAF25B

P356

J.SCHRES.2008.09.025

P1433

Schizophrenia Research

P1476

Weight effects associated with antipsychotics: a comprehensive database analysis.

@en

P2093

Antony Loebel

http://www.w3.org/2001/XMLSchema#string

Bruce Parsons

http://www.w3.org/2001/XMLSchema#string

Cynthia Siu

http://www.w3.org/2001/XMLSchema#string

Earl Giller

http://www.w3.org/2001/XMLSchema#string

Kathryn Williams

http://www.w3.org/2001/XMLSchema#string

Steven Romano

http://www.w3.org/2001/XMLSchema#string

P304

103-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SCHRES.2008.09.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

David B. Allison

P577

2009-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19321312

http://www.w3.org/2001/XMLSchema#string